Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • pharma-news
    • Coronavirus pandemic:...

    Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by manufacturers

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2020-04-11T13:18:42+05:30  |  Updated On 11 April 2020 1:18 PM IST
    Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by manufacturers

    New Delhi: With a recent notification, the Central Government has given powers to the National Pharmaceutical Pricing Authority (NPPA) under the paragraph 3 of the DPCO to excercise control over drug manufacturers to decide on their production of API and give directions to increase production

    Confirmation of the same was recently made in the gazette notification issued by the government that stated

    In exercise of the powers conferred by sections 3 and 5 of the Essential Commodities Act, 1955 (10 of 1955), the Central Government hereby directs that National Pharmaceutical Pricing Authority, established vide Government of India in the Ministry of Chemicals and Fertilizers Resolution No. 33/7/97-PI-I dated the 29th August 1997, published in Part I, Section 1 of the Gazette of India, Extraordinary, shall also exercise the functions of the Central Government in respect of paragraph 3 of the Drugs (Prices Control) Order, 2013 in addition to the functions specified in the Orders of the Government of India, in the Ministry of Chemicals and Fertilizers number S.O. 1394 (E), dated the 30th of May 2013 and S.O. 528(E), dated 15th February 2016.

    The para 3 of the DPCO deals with the Directions to manufactures of active pharmaceutical ingredients or bulk drugs or formulations and states that

    The government may,-

    (i) with a view to achieve adequate availability and to regulate the distribution of drugs, in case of emergency or in circumstances of urgency or in case of non- commercial use in the public interest, direct any manufacturer of any active pharmaceutical ingredient or bulk drug or formulation to increase the production and sell such active pharmaceutical ingredient or bulk drug to such manufacturer(s) of formulations and to direct formulators to sell formulations to institutions, hospitals or any agency as the case may be.

    (ii) for the purpose of giving any direction under subparagraph (i), call for such information from manufacturers of active pharmaceutical ingredients or bulk drugs or formulations, as it may consider necessary and such manufacturer shall furnish the required information within such time the Government may fix", say para 3 of DPCO states.

    To read the full details click on the following link:

    https://business.medicaldialogues.in/pdf_upload/pdf_upload-126994.pdf




    nppanational-pharmaceutical-pricing-authorityDPCOpowersAPIdrug makers

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok